Resultados globales: 1 registros encontrados en 0.01 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
6 p, 852.9 KB Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis : CLARIFY-MS study 6-month interim analysis / Brochet, Bruno (University of Bordeaux) ; Hupperts, Raymond (Maastricht University Medical Center) ; Langdon, Dawn (Royal Holloway University of London) ; Solari, Alessandra (Fondazione IRCCS Istituto Neurologico Carlo Besta) ; Piehl, Fredrik (Karolinska Institutet (Estocolm, Suècia)) ; Lechner-Scott, Jeannette (Newcastle University. John Hunter Hospital) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Selmaj, Krzysztof (Center for Neurology, Lodz, Poland) ; Valis, Martin (Charles University and University Hospital, Czech Republic) ; Rejdak, Konrad (Medical University of Lublin) ; Havrdova, Eva K. (Charles University, Prague, Czech Republic) ; Patti, Francesco (University of Catania) ; Alexandri, Nektaria (Merck Healthcare KGaA, Darmstadt, Germany) ; Nolting, Axel (Merck Healthcare KGaA, Darmstadt, Germany) ; Keller, Birgit (Universitat Autònoma de Barcelona. Departament de Medicina) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background Multiple sclerosis (MS) is a chronic disabling disease that is associated with negative effects on health-related quality of life (HRQoL) due to reduced physical and psychosocial functioning. [...]
2022 - 10.1016/j.msard.2021.103385
Multiple Sclerosis and Related Disorders, Vol. 57 (2022) , p. 103385  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.